Pharmanutra SpA (PHNU)

Milan
Currency in EUR
45.70
-0.15(-0.33%)
Real-time Data·
PHNU Scorecard
Full Analysis
Has a perfect Piotroski Score of 9
PHNU is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
45.7046.10
52 wk Range
45.0561.20
Key Statistics
Edit
Prev. Close
45.85
Open
46.1
Day's Range
45.7-46.1
52 wk Range
45.05-61.2
Volume
808
Average Volume (3m)
7.73K
1-Year Change
-5.56%
Book Value / Share
6.47
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PHNU Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
82.00
Upside
+79.43%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Pharmanutra SpA News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Pharmanutra Company Profile

Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, Europe, the Middle East, South America, Far East, and internationally. The company produces and distributes raw materials and active ingredients for the food, pharmaceutical, and dietary supplement industries. It also offers iron deficiency, inflammation, mineral and vitamin, muscle and joint, sports nutrition, ophthalmic, and night rest products; and medical instrumentation and software for body bioimpedance analysis. The company sells its products through sales representatives, wholesalers, pharmacies, para-pharmacies, agents, distributors, online sales, local partners, and tenders. Pharmanutra S.p.A. was founded in 2003 and is based in Pisa, Italy.

Employees
118
Market
Italy

Compare PHNU to Peers and Sector

Metrics to compare
PHNU
Peers
Sector
Relationship
P/E Ratio
26.5x22.4x12.0x
PEG Ratio
0.880.770.03
Price/Book
7.1x2.4x1.5x
Price / LTM Sales
3.8x1.3x0.9x
Upside (Analyst Target)
72.3%11.4%17.9%
Fair Value Upside
Unlock12.3%11.1%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 82.00
(+79.43% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.73%
Dividend Yield
2.18%
Industry Median 2.64%
Annualised payout
1.00
Paid annually
5-Years Growth
+16.80%
Growth Streak

Earnings

Latest Release
May 12, 2025
EPS / Forecast
0.25 / --
Revenue / Forecast
26.40M / --
EPS Revisions
Last 90 days

PHNU Income Statement

FAQ

What Is the Pharmanutra (PHNU) Stock Price Today?

The Pharmanutra stock price today is 45.70.

What Stock Exchange Does Pharmanutra Trade On?

Pharmanutra is listed and trades on the Milan Stock Exchange stock exchange.

What Is the Stock Symbol for Pharmanutra?

The stock symbol for Pharmanutra is "PHNU."

Does Pharmanutra Pay Dividends? What’s The Current Dividend Yield?

The Pharmanutra dividend yield is 2.18%.

What Is the Pharmanutra Market Cap?

As of today, Pharmanutra market cap is 440.31M.

What Is Pharmanutra's Earnings Per Share (TTM)?

The Pharmanutra EPS (TTM) is 1.73.

When Is the Next Pharmanutra Earnings Date?

Pharmanutra will release its next earnings report on 07 Sept 2025.

From a Technical Analysis Perspective, Is PHNU a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Pharmanutra Stock Split?

Pharmanutra has split 0 times.

How Many Employees Does Pharmanutra Have?

Pharmanutra has 118 employees.

What is the current trading status of Pharmanutra (PHNU)?

As of 16 Jul 2025, Pharmanutra (PHNU) is trading at a price of 45.70, with a previous close of 45.85. The stock has fluctuated within a day range of 45.70 to 46.10, while its 52-week range spans from 45.05 to 61.20.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.